# Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet

> **NCT06817811** · PHASE1 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 24 (actual)

## Conditions studied

- Health

## Interventions

- **DRUG:** Apixaban 5 mg Film-Coated Tablet (produced by PT Dexa Medica)
- **DRUG:** Eliquis® 5 mg film-coated tablet (Bristol-Myers Squibb Company, Puerto Rico, packed and released by Bristol-Myers Squibb S.r.l., Italy, imported by PT Pfizer Indonesia)

## Key facts

- **NCT ID:** NCT06817811
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2021-04-24
- **Final completion:** 2021-06-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817811, "Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06817811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*